SCHEMBL23389143

SCHEMBL23389143

CC(C)(C)OC(=O)NC1CCCN(Cc2cc3cc(OC(F)(F)F)ccc3[nH]2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDR1 Q08345 7/20 0.47
▸ ROCK2 O75116 4/20 0.44
▸ MCHR1 Q99705 1/20 0.43
▸ JAK2 O60674 1/20 0.43
▸ PRKD3 O94806 1/20 0.43
▸ PRKCG P05129 1/20 0.43
▸ PHKG2 P15735 1/20 0.43
▸ RPS6KB1 P23443 1/20 0.43
▸ MARK3 P27448 1/20 0.43
▸ PRKCI P41743 1/20 0.43
▸ CLK2 P49760 1/20 0.43
▸ IRAK1 P51617 1/20 0.43
▸ RPS6KA3 P51812 1/20 0.43
▸ PRKCD Q05655 1/20 0.43
▸ MAP4K2 Q12851 1/20 0.43
▸ STK3 Q13188 1/20 0.43
▸ CAMK2B Q13554 1/20 0.43
▸ CAMK2G Q13555 1/20 0.43
▸ CAMK2D Q13557 1/20 0.43
▸ PKN2 Q16513 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29943544 1.00 DDR1 (0.47) DDR1ROCK2MCHR1JAK2PRKD3
SCHEMBL23389145 1.00 DDR1 (0.47) DDR1ROCK2MCHR1JAK2PRKD3
SCHEMBL23389181 0.82 KMT2A (0.51) KDM4EGAAKMT2AHRH3MAPT
SCHEMBL29943552 0.82 KMT2A (0.51) KDM4EGAAKMT2AHRH3MAPT
SCHEMBL23389178 0.82 KMT2A (0.51) KDM4EGAAKMT2AHRH3MAPT
SCHEMBL23389100 0.79 ROCK2 (0.44) DDR1ROCK2MCHR1JAK2PRKD3
SCHEMBL23389097 0.79 ROCK2 (0.44) DDR1ROCK2MCHR1JAK2PRKD3
SCHEMBL23389119 0.78 ROCK2 (0.48) DDR1ROCK2JAK2PRKD3PRKCG
SCHEMBL23389118 0.78 ROCK2 (0.48) DDR1ROCK2JAK2PRKD3PRKCG
SCHEMBL16528537 0.76 DDR1 (0.54) DDR1MCHR1SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263366-A2 CASPASE 6 INHIBITORS AND USES THEREOF SHANGPHARMA INNOVATION INC. 2025-08-21 — — US disclosed
US-20230202974-A1 CASPASE 6 INHIBITORS AND USES THEREOF UNIV CALIFORNIA (US) 2023-06-29 — — US disclosed
WO-2021102361-A1 CASPASE 6 INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-05-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202974-A1 CASPASE 6 INHIBITORS AND USES THEREOF CASP6, CASP1, CASP10 DDR1 1956/4885ROCK2 3549/4885MCHR1 4679/4885
US-20250263366-A2 CASPASE 6 INHIBITORS AND USES THEREOF CASP6, CASP1, CASP10 DDR1 1956/4885ROCK2 3549/4885MCHR1 4679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback